$MDNAF $MDNA.to MDNA113 Update Ahead of the NHP data to be presented at #AACR26 04/21

First-in-class tumor-targeted PD-1 × IL-2 immunotherapy:
Exceptional tumor selectivity & potent anti-tumor activity
Masked bi-specific design for immunologically cold solid tumors